Technology
Health
Biotechnology

IMV

1,909

$1.65
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-3.51%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell IMV and other stocks, options, ETFs, and crypto commission-free!

About IMV

IMV Inc. Common Shares, also called IMV, is a clinical-stage biopharmaceutical company, which engages in the research and development of immunotherapies for the treatment of infectious diseases. Read More Its proprietary drug delivery platform DPX develops a pipeline of novel therapeutic and preventive approaches for cancer and other serious diseases. The company was founded by Warwick Kimmins and Brian E. Lowe on March 28, 2000 and is headquartered in Dartmouth, Canada.

CEO
Frederic Ors
Employees
—
Headquarters
Dartmouth, Nova Scotia
Founded
2000
Market Cap
78.09M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
554.57K
High Today
$1.78
Low Today
$1.61
Open Price
$1.78
Volume
123.88K
52 Week High
$18.80
52 Week Low
$1.35

Collections

Technology
Health
Biotechnology
Medical
Biopharmaceutical
Cancer Prevention
Pharmaceutical
2018 IPO

IMV News

Financial PostMar 25

IMV to Announce Fourth Quarter and Full Year 2019 Financial and Operational Results and Host Investor Conference Call and Webcast on March 31, 2020

DARTMOUTH, Nova Scotia — IMV Inc. (“IMV” or the “Corporation”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of i
166

IMV Earnings

-$0.13
-$0.09
-$0.04
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
— per share
Actual
Expected Nov 6, Pre-Market

People Also Bought

Inovio

208,169

$8.72

+21.96%

Inovio

208,169

$8.72

+21.96%

Aurora Cannabis

828,182

$1.02

+12.71%

TherapeuticsMD

16,661

$1.07

-17.05%

Plug Power

254,116

$3.70

-2.89%

You May Also Like

TGH
JBHT
APXTW
FSS
AEZS
ZIXI
ASPS
EPV
PAHC
JFR
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy IMV

Market Price$1.65
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell IMV stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up